Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patient Characteristics and Individualization of Biologic Therapy.

Immunology and allergy clinics of North America - 1 May 2017

Draikiwicz Steven, Oppenheimer John

Abstract excerpt

Progress in the understanding of disease processes has provided additional therapeutic targets, best exemplified by the increasing role of biologics in the clinical armamentarium. This article provides a focused review of current treatment paradigms and pathophysiology for asthma, atopic dermatitis, urticaria, as well as C1 inhibitor deficiency. It elucidates the populations in which biologics were studied for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Asthmatic Agents
Share to Antibodies, Monoclonal
Share to Asthma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulins, Intravenous

Share to Phenotype

Share to Precision Medicine

Share to Treatment Outcome

Share to Urticaria

Source

Identifiers

PMID: 28366476
DOI: 10.1016/j.iac.2017.01.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patient Characteristics and Individualization of Biologic Therapy.PMID 28366476Read ↗

Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.Semantic proximity Read ↗

Severe asthma and personalized approach in the choice of biologic.Semantic proximity Read ↗

Pharmacogenomics of Anti-Inflammatory Therapy: Toward Personalized Use of Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, and BiologicsSemantic proximity Read ↗

Metabolic considerations of drugs in the treatment of allergic diseases.Semantic proximity Read ↗

Biological treatment provides disease-modifying immunological effectsSemantic proximity Read ↗

Eculizumab for atypical haemolytic uraemic syndrome: what next?Semantic proximity Read ↗

Pharmacogenomics for the efficacy and side effects of antihistaminesSemantic proximity Read ↗

Management of adverse reactions to biologic agents.Semantic proximity Read ↗

Treatment of Chronic Spontaneous Urticaria With Benralizumab: Report of Primary Endpoint Completer Analysis, Secondary and Exploratory EndpointsSemantic proximity Read ↗

Personalized therapies in pediatric inflammatory and autoimmune diseases.Semantic proximity Read ↗

Biologic Therapy and Asthma.Semantic proximity Read ↗

Advanced phenotyping in hypersensitivity drug reactions to NSAIDs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.